Pfizer Toviaz Clears FDA For OAB: Three-Year Window To Establish Detrol Successor
This article was originally published in The Pink Sheet Daily
Executive Summary
Anti-muscarinic agent acquired from Schwarz in 2006 to hit U.S. market in 2009; in time to build sales before Pfizer’s Detrol goes off-patent in 2012.